Abstract
Movement disorders can be defined as neurologic syndromes in which there is either an excess of movement (commonly referred to as hyperkinesia, dyskinesia, and abnormal involuntary movement), or a paucity of voluntary and automatic movements unrelated to weakness or spasticity. The latter group can be referred to as hypokinesia (decreased amplitude of movement), but bradykinesia (slowness of movement) and akinesia (loss of movement) are common alternatives. The parkinsonian syndromes are the most common cause of paucity of movement; other hypokinetic disorders represent only a small group of patients. Basically, movement disorders are conveniently divided into parkinsonism and all other types. Gait is affected by most types of movement disorders, including parkinsonism, dystonia, chorea, myoclonus, and cerebellar ataxia.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Hughes AJ, Daniel SE, Kilford L, Lees AJ: Accuracy of clinical diagnosis of idiopathic Parkinson’s disease: a clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiat 1992, 55: 181–184.
Wichmann T, DeLong MR: Pathophysiology of parkinsonian motor abnormali ties. Adv Neurol 1993, 60: 53–61.
Duvoisin RC, Eldridge R, Williams A, et al.: Twin study of Parkinson disease. Neurology 1981, 31:77–80.
Chase, TN, Mouradian MM, Engber TM: Motor response complications and the function of striatal efferent systems. Neurology 1993, 43 (suppl 6): S23 - S27.
Mouradian MM, Juncos JL, Fabbrini G, et al.: Motor fluctuations in Parkinson’s disease: central pathophysiological mechanisms, part II. Ann Neurol 1988, 24:372–378.
Laitinen LV, Bergenheim AT, Hariz MI: Leksell’s posteroventral pallidotomy in the treatment of Parkinson’s disease. J Neurosurg 1992, 76: 53–61.
Limousin P, Krack P, Pollak P, et al.: Electrical stimulation of the subthalamic nucleus in advanced Parkinson’s disease. N Engl J Med 1998, 339:1105–1111.
Steele RC, Richardson JC, Olszewski J: Progressive supranuclear palsy: a heterogeneous degeneration involving the brain stem, basal ganglia and cerebellum with vertical gaze and pseudobulbar palsy, nuchal dystonia and dementia. Arch Neurol 1964, 10: 333–359.
Lepore FE, Duvoisin RC: “Apraxia” of eyelid opening: an involuntary levator inhibition. Neurology 1985, 35: 423–427.
Lantos PL: The Neuropathology of Progressive Supranuclear Palsy. In Progressive Supranuclear Palsy: Diagnosis, Pathology and Therapy. Edited by Tolosa E, Duvoisin R, Cruz-Sanchez FE New York: Springer-Verlag, Wein; 1994: 137–152.
Brooks DJ: PET Studies in Progressive Supranuclear Palsy. In Progressive Supranuclear Palsy: Diagnosis, Pathology, and Therapy. Edited by Toloso E, Duvoisin R, Cruz-Sanchez FF. New York: Springer-Verlag; 1994: 119–132.
Graham JG, Oppenheimer DR: Orthostatic hypotension and nicotinic sensitivity in a case of multiple system atrophy. J Neurol Neurosurg Psychiatry 1969, 32: 28–34.
Lantos PL, Papp MI: Cellular pathology of multiple system atrophy: a review. J Neurol Neurosurg Psychiatry 1994, 57: 129–133.
Gilman S, Koeppe RA, Junck L, et al.: Patterns of cerebral glucose metabolism detected with positron emission tomography differ in multiple system atrophy and olivopontocerebellar atrophy. Ann Neurol 1994, 36:166–175.
Rutledge JN, Schallert T, Hall S: Magnetic resonance imaging in parkinsonisms. Adv Neurol 1993, 60: 529–534.
Rebeiz JJ, Kolodny EH, Richardson EP Jr: Corticodentatonigral degeneration with neuronal achromasia. Arch Neurol 1968, 18: 20–33.
Uchihara T, Mitani K, Mori H, et al.: Abnormal cytoskeletal pathology peculiar to corticobasal degeneration is different from that of Alzheimer’s disease or progressive supranuclear palsy. Acta Neuropathol 1994, 88:379–383.
Klawans HL: Hemiparkinsonism as a late complication of hemiatrophy: a new syndrome. Neurology 1981, 31: 625–628.
Perry RH, Irving D, Blessed G, et al.: Senile dementia of Lewy body type. J Neurol Sci 1990, 95:119–139.
Hakim S, Adams RD: The special clinical problem of symptomatic hydrocephalus with normal cerebrospinal fluid pressure: observations on cerebrospinal fluid hydrodynamics. J Neurol Sci 1965, 2: 307–327.
Greene PE, Kang UJ, Fahn S: Spread of symptoms in idiopathic torsion dystonia. Mov Disord 1995, 10: 143–152.
Kramer PL, Heiman GA, Gasser T, et al.: The DYT1 gene on 9q34 is responsible for most cases of early limb-onset idiopathic torsion dystonia in non-Jews. Am J Hum Genet 1994, 55:468–475.
Rothwell JC, Obeso JA, Day BL, Marsden CD: Pathophysiology of dystonias. In Motor Control Mechanisms in Health and Disease. Edited by Desmedt JE. New York: Raven Press; 1983: 851–863.
Marsden, CD, Obeso JA, Zarranz JJ, Lang AE: The anatomical basis of symptomatic hemidystonia. Brain 1985, 108: 461–483.
Zilber N, Korcyn AD, Kahana E, et al.: Inheritance of idiopathic torsion dystonia among Jews. J Med Genet 1984, 21:13–26.
Waddy HM, Fletcher NA, Harding AE, Marsden CD: A genetic study of idiopathic focal dystonias. Ann Neural 1991, 29: 320–324.
Bressman SB, deLeon D, Brin MF, et al.: Idiopathic dystonia among Ashkenazi Jews: evidence for autosomal dominant inheritance. Ann Neurol 1989, 26:612–620.
Bressman SB, Sabatti C, Raymond D, et al.: The DYT1 phenotype and guidelines for diagnostic tsting. Neurology 2000, 54:1746–1752.
Holmgren G, Ozelius L, Forsgren L, et al: Adult-onset idiopathic torsion dystonia is excluded from the DYT1 region (9q34) in a Swedish family. J Neurol Neurosurg Psychiatry 1995, 59: 178–181.
Bressman SB, Hunt AL, Heiman GA, et al.: Exclusion of the DYT1 locus in a non-Jewish family with early-onset dystonia. Mov Disord 1994, 9:626–632.
Leube B, Rudnicki D, Ratzlaff T, et al.: Idiopathic torsion dystonia: assignment of a gene to chromosome 18p in a German family with adult onset, autosomal dominant inheritance and purely focal distribution. Hum Mol Genet 1996, 5:1673–1677.
Ichinose H, Ohye T, Takahashi E, et al: Hereditary progressive dystonia with marked diurnal fluctuation caused by mutations in the GTP cyclohydrolase I gene. Nat Genet 1994, 8: 229–235.
Nygaard TG, Waran SP, Levine RA, et al.: Dopa-responsive dystonia simulating cerebral palsy. Pediat Neurol 1994,11:236–240.
Bull PD, Thomas GR, Rommens JM, et al.: The Wilson disease gene is a putative copper transporting P-type ATPase similar to the Menkes gene [published erratum appears in Nat Genet 1994, 6(2):214]. Nat Genet 1993, 5:327–237.
Tanzi RE, Petrukhin K, Chernov I, et al.: The Wilson disease gene is a copper transporting ATPase with homology to the Menkes disease gene. Nat Gen 1993, 5:344–350.
Thomas GR, Forbes JR, Roberts EA, et al.: The Wilson disease gene: spectrum of mutations and their consequences. Nat Genet 1995, 9:210–217.
Wiebers DO, Hollenhorst RW, Goldstein NP: The ophthalmologic manifestations of Wilson’s disease. Mayo Clin Proc 1977, 52: 409–416.
Higgins JJ, Patterson MC, Papadopoulos NM, et al.: Hypoprebetalipoproteinemia, acanthocytosis, retinitis-pigmentosa, and pallidal degeneration (HARP syndrome). Neurology 1992, 42:194–198.
Sethi KD, Adams RJ, Loring DW, Gammal TE: Hallervorden-Spatz syndrome: clinical and magnetic resonance imaging correlations. Ann Neurol 1988, 24: 692–694.
Feinberg TE, Cianci CD, Morrow JS, et al.: Diagnostic tests for choreoacanthocytosis. Neurology 1991, 41:1000–1006.
Rubio JP, Danek A, Stone C, et al.: Chorea-acanthocytosis: genetic linkage to chromosome 9q21. Am J Hum Genet 1997; 61:899–908.
Witt TN, Danek A, Hein MU, et al.: McLeod syndrome: a distinct form of neuroacanthocytosis. J Neurol 1992, 239:302–306.
Orrell RW, Amrolia PJ, Heald A, et al.: Acanthocytosis, retinitis pigmentosa, and pallidal degeneration: a report of three patients, including the second reported case with hypoprebetalipoproteinemia (HARP syndrome). Neurology 1995, 45:487–491.
Huntington’s Disease Collaborative Research Group: A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington’s disease chromosomes. Cell 1993, 72: 971–983.
Albin RL, Tagle DA: Genetics and molecular biology of Huntington’s disease. Trends Neurosci 1995, 18: 11–14.
Kremer B, Goldberg P, Andrew SE, et al.: A worldwide study of the Huntington’s disease mutation-the sensitivity and specificity of measuring CAG repeats. N Engl J Med 1994, 330:1401–1406.
Bressman SB, Risch NJ: Genetics of Movement Disorders: Dystonia, Dopa-responsive Dystonia and Huntington’s Disease. In Movement and Allied Disorders in Childhood. Edited by Robertson MM, Eapen V. London: John Wiley and Sons; 1995: 327–356.
Myers RH, MacDonald ME, Koroshetew J, et al.: De novo expansion of a (CAG)n repeat in sporadic Huntington’s disease. Nat Genet 1993, 5:168–173.
Martin WRW, Calne DB: Imaging Techniques and Movement Disorders. In Movement Disorders. Edited by Marsden CD, Fahn S. Boston: Butterworth; 1987: 14–16.
Harris GJ, Pearlson GD, Peyser CE, et al.: Putamen volume reduction on magnetic resonance imaging exceeds caudate changes in mild Huntington’s disease. Ann Neurol 1992,31:69–75.
DeLong MR: Primate models of movement disorders of basal ganglia origin. Trends Neurosci 1990, 13: 281–285.
Pauls DL, Raymond CL, Stevenson JM, Leckman JF: A family study of Gilles de la Tourette syndrome. Am J Human Genet 1991, 43: 154–163.
Singer HS, Hahn IH, Krowiak E, et al.: Tourette’s syndrome: a neurochemical analysis of postmortem cortical brain tissue. Ann Neurol 1990, 27:443–446.
Obeso JA, Rothwell JC, Marsden CD: The neurophysiology of Tourette syndrome. Adv Neurol 1982, 35: 105–114.
Elble RJ: Mechanisms of Physiological Tremor and Relationship to Essential Tremor. In Handbook of Tremor Disorders. Edited by Findley LJ, Koller WC. New York: Marcel Dekker; 1995.
Vitek JL, Wichmann T, DeLong MR: Current Concepts of Basal Ganglia Neurophysiology Relative to Tremorgenesis. In Handbook of Tremor Disorders. Edited by Findley LJ, Koller WC. New York: Marcel Dekker; 1995: 37–50.
Louis ED, Ford B, Lee H, et al.: Diagnostic criteria for essential tremor: a population perspective. Arch Neural 1998, 55:222–227.
Caparros-Lefebvre D, Ruchoux MM, Blond S, et al.: Long-term thalamic stimulation in Parkinson’s disease. Neurology 1994, 44:1856–1860.
Bogousslaysky J, Maeder P, Regli F, Meuli R: Pure midbrain infarction: clinical syndromes, MRI, and etiologic patterns. Neurology 1994, 44: 2032–2040.
Wall M: Brainstem Syndromes. In Neurology in Clinical Practice. Bradley WG, Daroff RB, Fenichel GM, Marsden CD. Boston: Butterworth-Heinemann; 1991: 347–362.
Weiner WJ, Lang AE: Movement Disorders: A Comprehensive Survey. Mount Kisco, NY: Futura; 1989: 457–530.
Carpenter MB: Core Text of Neuroanatomy, edn 3. Baltimore: Williams & Wilkins; 1985.
Shibasaki H, Kuriowa Y: Electroencephalographic correlates of myoclonus. Electroencephalog Clin Neurophysiol 1975, 39: 455–463.
Shibasaki H, Yamashita Y, Kuriowa Y: Electroencephalographic studies of myoclonus; myoclonus-related cortical spikes and high amplitude somatasensory evoked potentials. Brain 1978, 101: 447–460.
Shibasaki H, Yamashita Y, Tobimatsu S, Neshige R: Electroencephalographic correlates of myoclonus. In Adv Neurol 1986, 43: 357–372.
Young RH, Shahani BT: Asterixis: one type of negative myoclonus. Adv Neurol 1986, 43: 137–156.
Kang UJ, Burke RE, Fahn S: Natural history and treatment of tardive dystonia. Mov Disord 1986, 1: 193–208.
Barker FG, Jannetta PJ, Bissonette DJ, et al.: Microvascular compression for hemifacial spasm. J Neurosurg 1995, 82:201–210.
Jannetta PJ: Cranial Rhizotomies. In Neurological Surgery. Edited by Youmans JR. vol 6, edn 3. Philadelphia: WB Saunders; 1990, 4169–4182.
Williams DT, Ford B, Fahn S: Phenomenology and psychopathology related to psychogenic movement disorders. Adv Neural 1995, 65: 231–257.
Fahn S: Paroxysmal Dyskinesias. In Movement Disorders III. Edited by Marsden CD, Fahn S. Oxford: Butterworth-Heinemann; 1994: 310–345.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2003 Springer Science+Business Media New York
About this chapter
Cite this chapter
Fahn, S., Greene, P.E., Ford, B., Bressman, S.B. (2003). Movement Disorders. In: Rosenberg, R.N. (eds) Atlas of Clinical Neurology. Current Medicine Group, London. https://doi.org/10.1007/978-1-4757-4552-8_9
Download citation
DOI: https://doi.org/10.1007/978-1-4757-4552-8_9
Publisher Name: Current Medicine Group, London
Print ISBN: 978-1-4757-4554-2
Online ISBN: 978-1-4757-4552-8
eBook Packages: Springer Book Archive